Biography
Lidija Banjac is a specialist in the field of pediatrics and neonatology. She has completed her PhD at Montenegro University School of Medicine. She is head of the Department of neonatology and Assistant professor at the Medical faculty in Podgorica. She has published more than 40 papers in journals in the field of pediatrics and neonatology.
Abstract
Neonatal cerebral sinovenous thrombosis (CSVT) is a life-threatening neurological disorder. Neonates represent up to 50% of all reported pediatric cases. CSVT is increasingly recognized in neonatal practice. This study presents two newborns with CSVT from our neonatal center and analyzes their clinical findings. The first newborn (female) admitted in the 6th day of life because of deterioration of consciousness and the occurrence of recurrent seizures. Magnetic resonance venography demonstrating thrombosis of the right transverse sinus and the left transverse and sigmoid sinus, hemorrhagic infarcts and parenchymal haemorrhage. The patient had difficult clinical course and received anticoagulation therapy. She had neurological deficits at discharge from the hospital (periventricular leukomalacia, epilepsy). Second newborn (male) was admitted in a 3-day because of motor weakness, an episode of seizures and the central facial paresis. There was no disturbance of consciousness. Magnetic resonance venography showed thrombosis of the left transverse and sigmoid sinus. There were no signs of intracranial hemorrhage. The patient had mild clinical course and was not treated with anticoagulation therapy. He had a discrete neurological deficit at discharge from the hospital. In both patients, the diagnosis of hypercoagulable diseases were set (first newborn - protein S deficiency, the second - thrombophilia). They have a positive family history of hypercoagulable disease. CSVT presents with wide spectrum of neurological sings. Hypercoagulable state was the most common predisposing factor for CSVT. Newborns with neurological sings and positive family history of hypercoagulable disease should be tested on CSVT.
Biography
Guadalupe Cordero Gonzalez is a Neonatologist attending at the Neonatal Intensive Care Unit in the Instituto Nacional de Perinatologia at Mexico City. She has completed her Post-graduate studies from Instituto Nacional de Pediatria and Instituto Nacional de Perinatologia in Mexico City, and completed a Master’s in Medical Education from Interamerican University in Mexico. She is the NICU Chief at INPer and has published more than 20 papers in reputed journals.
Abstract
Introduction: 95% of monochorionic-monoamniotic twins have veno-arterial placental anastomoses allowing blood transfusion from one to another. Without treatment, both babies are affected. Material and methods: a retrospective analysis of the outcomes of 55 monochorionic-monoamniotic pregnancies treated at Instituto Nacional de PerinatologÃa (INPer) in México City, from January 1999 to July 2014 was performed. Data were obtained from clinical charts; percentages, means and standard deviations were calculated for descriptive analysis and t Student test was applied to compare quantitative variables and chi square for qualitative ones, with SPSS v. 20. Results: 48 babies were alive, 38 died before birth and 20 continued their treatment outside of INPer. Survival correlated with Quintero stage at the diagnostic and treatment time: stage 1(83%), 2 (35%), 3 (67.5%), 4 (50%). Mean gestational age at lasser coagulation was 23.3 weeks. 93.7% born by cesarean section, at 31.2 weeks (56 days after coagulation); mean birth weight: 1399.8 g. Statistical difference in hematocrit values between donors (47.2 ±10) vs receptors (48.9 ±11.2) was observed (p=0.000); frequent complications were: hydrops (4%), necrotizing enterocolitis (4%) and thrombosis (2%) and main morbidities were retinopathy (14%), bronchopulmonary dysplasia (10%) and neurodevelopmental disability (10%). Conclusions: survival and outcomes of twin to twin transfusion syndrome patients are related to Quintero stage and gestational age at birth, so that, best chance of living without sequel are correct and early detection and treatment when is needed. Key words: Transfusion, twin to twin syndrome, lasser coagulation